The DOI matches its Crossref record; 229 of the 231 references it cites were found in a registry or an index.
On Neurodegenerative Diseases, Models, and Treatment Strategies: Lessons Learned and Lessons Forgotten a Generation Following the Cholinergic Hypothesis
Abstract
Life's Journey If life is indeed a journey, then poetry must be the map that reveals all its topographic possibilitiesellipsis while science is the compass that keeps us from getting lost. -R. T. Bartus, Simple Words for Complex Lives, (c) 1998 In the nearly 20 years since the cholinergic hypothesis was initially formulated, significant progress has been achieved. Initial palliative treatments for Alzheimer's disease (AD) have proven beneficial and have gained FDA approval, the use of animal models for studying AD and other neurodegenerative diseases has achieved wider acceptance, and important insight into the potential causes and pathogenic variables associated with various neurodegenerative diseases continues to increase. This paper reviews the current status of the cholinergic hypothesis in the context of continuing efforts to improve upon existing treatments for AD and explores the role that animal models might continue to play. Using the benefit of hindsight, particular emphasis is placed on an analysis of the approaches, strategies, and assumptions regarding animal models that proved useful in developing the initial treatments and those that did not. Additionally, contemporary issues of AD are discussed within the context of the cholinergic hypothesis, with particular attention given to how they may impact the further refinement of animal models, and the development of even more effective treatments. Finally, arguments are presented that, despite the deserved enthusiasm and optimism for identifying means of halting the pathogenesis of AD, a clear need for more effective palliative treatments will continue, long after successful pathogenic treatments are available. This review, therefore, focuses on issues and experiences intended to: (a) facilitate further development and use of animal models for AD and other neurodegenerative diseases, and (b) accelerate the identification of newer, even more effective treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The anatomical organization of this neuronal system predicts that abnormalities in cholinergic activity profoundly impairs cortical and hippocampal information processing (e.g., Bartus, 2000; Mesulam, 2004; Sarter et al, 2005a).”
From Modes and models of forebrain cholinergic neuromodulation of cognition (2011) · cites this paper as Bartus, 2000
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Self-citationAlzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Psychopharmacology: The third generation of progress
O’Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,020
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Donepezil Study Group* (1998) · Neurology · doi:10.1212/wnl.50.1.136 · Cited by 1,618
Human Memory and the Cholinergic System
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,398
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
Bowen, D. M., Smith, C. B., White, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,313
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Flagged first, then by citations
2 of the 231 references couldn’t be matched to a known paper.
Research works printed but not linked: 19
- Sarter M., 1991, Cholinergic controversies, Trends Neurosci., 14, 483
- Tariot, 1996, Contemporary treatment approaches to Alzheimer's disease, Consult. Pharm., 11, 16
- Bartus, 1995, Aging in the Rhesus monkey: Debilitating effects on short term memory, J. NIH Res., 7, 69
- Sathananthan, 1975, Cerebral vasodilators: A review, 155
- Gallagher, 1998, Effects of aging on cognition and hippocampal/cortical systems, Soc Neurosci. Abstr., 24
- Bartus, 1986, Commentary on animal models of Alzheimer's and Parkinson's disease, Integr. Psychiatry, 4, 74
- Bartus, R., C. Flicker, and R. Dean. 1983. Logical principles in the development of animal models of age-related memory loss. In Clinical and Preclinical Assessment in Geriatric Psychopharmacology (T. Crook, Ed.), pp. 263–299. Mark Powley Associates, New Caanan, CT.
- Bartus, 1983, Behavioral and pharmacological studies using animal models of aging: Implications for studying and treating dementia of Alzheimer's type, Banbury Rep., 1515, 207
- Bartus, R. 1979. The effects of aging on visual memory, sensory processing and discrimination learning in a nonhuman primate. In Aging: Sensory Systems and Communication in the Elderly (J. Ordy, Ed.), pp. 85–113. Raven Press, New York.
- Moss, 1986, Effects of Aging on visual recognition memory in the Rhesus monkey, Primate Rep., 14, 133
- Bartus, 1979, Recent memory in aged nonhuman primates: Hypersensensitivity to visual interference during retention, Exp. Aging, 5, 385, 10.1080/03610737908257214 · DOI
- Bartus, R., T. Crook, and R. Dean. 1987. Current progress in treating age-related memory problems: A perspective from animal preclinical and human clinical research. In Geriatric Clinical Pharmacology (G. Wood and R. Strong, Eds.), pp. 71–94. Raven Press, New York.
- Bartus, R., and R. Dean. 1988. Effects of cholinergic and adrenergic enhancing drugs on memory in aged monkeys. In Current Research in Alzheimer Therapy (E. Giacobini and R. Becker, Eds.), pp. 179–190. Taylor and Francis, New York.
- McEntee, 1991, Treatment of adult-onset cognitive disorders: results of multicenter trials, Psychopharmacol. Bull., 27, 41
- Dean, 1982, Drug induced memory impairments in nonhuman primates, Soc. Neurosci. Abstr., 8, 322
- Ogura, 1993, MK-801 impairs recogition memory in rhesus mondeys: comparison with cholinergic drugs, Pharmacol. Exp. Ther., 266, 60
- Herz, 1960, Die Gedentung der Gahung fur die wirkung von scopolamin und ahnlichen, Z. Biol., 112, 104
- Crowley, 1999, Big study hopes to find if Alzheimer's can be prevented in memory-impaired, Wall Street Journal.
- Pang, 1998, Alzheimer's Disease, AAPS News, 1, 11
Cited by
Sorted by citations
Items 201–300 of 852
Azami, N., Piri, M., Oryan, S., Jahanshahi, M., Babapour, V., & Zarrindast, M. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.01.003 · Cited by 61
Sarter, M. F., & Turchi, J. N. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000048633 · Cited by 64
The contribution of the study of neurodegenerative disorders to the understanding of human memory
Panegyres, P. K. (2004) · QJM · doi:10.1093/qjmed/hch096 · Cited by 60
Neuronal Nicotinic Acetylcholine Receptors: Involvement in Alzheimer’s Disease and Schizophrenia
Woodruff‐Pak, D. S., & Gould, T. J. (2002) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582302001001002 · Cited by 60
Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats
Rodrigues, R. J., Canas, P. M., Lopes, L. V., Oliveira, C. R., & Cunha, R. A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.025 · Cited by 60
Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons
G.‐Coviella, I. L., Follettie, M. T., Mellott, T. J., Kovacheva, V., Slack, B. E., Diesl, V., Berse, B., Thies, R. S., & Blusztajn, J. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502097102 · Cited by 60
Physiological Role of Amyloid Beta in Neural Cells: The Cellular Trophic Activity
Cárdenas‐Aguayo, M. D. C., Silva‐Lucero, M., Cortés-Ortiz, M., Jimnez-Ramos, B., Gomez‐Virgilio, L., Ramrez-Rodrguez, G., Arroyo, E. V., Fiorentino-Prez, R., Garca, U., Luna-Muoz, J., et al. (2014) · InTech eBooks · doi:10.5772/57398 · Cited by 67
Xu, J., Rong, S., Xie, B., Sun, Z., Zhang, L., Wu, H., Yao, P., Zhang, X., Zhang, Y., & Liu, L. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.07.006 · Cited by 59
New Potent Acetylcholinesterase Inhibitors in the Tetracyclic Triterpene Series
Sauvaître, T., Barlier, M., Herlem, D., Gresh, N., Chiaroni, A., Guénard, D., & Guillou, C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070536w · Cited by 59
Acetylcholinesterase inhibitors from the roots ofangelica dahurica
Kim, D. K., Lim, J., Yang, J. H., Eom, D. O., Eun, J. S., & Leem, K. H. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02977004 · Cited by 58
Traissard, N., Herbeaux, K., Cosquer, B., Jeltsch‐David, H., Ferry, B., Galani, R., Pernon, A., Majchrzak, M. J., & Cassel, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301116 · Cited by 58
Rasch, B., Gais, S., & Born, J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.6 · Cited by 57
The two faces of Coprinus comatus —Functional properties and potential hazards
Nowakowski, P., Naliwajko, S. K., Markiewicz‐Żukowska, R., Borawska, M. H., & Socha, K. (2020) · Phytotherapy Research · doi:10.1002/ptr.6741 · Cited by 61
Binder, S., Dere, E., & Zlomuzica, A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.04.002 · Cited by 56
Effects of nicotine and mecamylamine on cognition in rhesus monkeys
Katner, S. N., Davis, S. A., Kirsten, A. J., & Taffe, M. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1804-z · Cited by 58
Barrett, G. L., Reid, C. A., Tsafoulis, C., Zhu, W.-M., Williams, D. A., Paolini, A. G., Trieu, J., & Murphy, M. (2009) · Hippocampus · doi:10.1002/hipo.20598 · Cited by 57
Paying attention to smell: cholinergic signaling in the olfactory bulb
Dâ€TMSouza, R. D., & Vijayaraghavan, S. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00021 · Cited by 57
Mellott, T. J., Huleatt, O. M., Shade, B. N., Pender, S. M., Liu, Y. B., Slack, B. E., & Blusztajn, J. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170450 · Cited by 54
Emerging prospects for the disease-modifying treatment of Alzheimer's disease
Walker, L. C., Ibegbu, C., Todd, C. W., Robinson, H. L., Jucker, M., LeVine, H., & Gandy, S. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.12.015 · Cited by 58
Mostofi, M., Ziarani, G. M., Mahdavi, M. R., Moradi, A., Nadri, H., Emami, S., Alinezhad, H., Foroumadi, A., & Shafiee, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.08.061 · Cited by 57
Han, R.-W., Zhang, R., Xu, H., Chang, M., Peng, Y., & Wang, R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.002 · Cited by 55
Zhao, Q., Matsumoto, K., Tsuneyama, K., Tanaka, K., Li, F., Shibahara, N., Miyata, T., & Yokozawa, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11115fp · Cited by 57
Jackson, P. A., Forster, J. S., Bell, J. G., Dick, J., Younger, I., & Kennedy, D. O. (2016) · Nutrients · doi:10.3390/nu8020086 · Cited by 55
Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease
Więckowska, A., Wichur, T., Godyń, J., Bucki, A., Marcinkowska, M., Siwek, A., Więckowski, K., Zaręba, P., Knez, D., Głuch‐Lutwin, M., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00024 · Cited by 55
Acetylcholine Facilitates Recovery of Episodic Memory after Brain Damage
Croxson, P. L., Browning, P. G. F., Gaffan, D., & Baxter, M. G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2947-12.2012 · Cited by 56
Single-neuron firing cascades underlie global spontaneous brain events
Liu, X., Leopold, D. A., & Yang, Y. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105395118 · Cited by 53
Antidepressant drugs and memory: Insights from animal studies
Monleón, S., Vinader‐Caerols, C., Arenas, M. C., & Parra, A. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.07.001 · Cited by 54
Attention-modulating effects of cognitive enhancers
Levin, E. D., Bushnell, P. J., & Rezvani, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.008 · Cited by 54
Association of basal forebrain volumes and cognition in normal aging
Wolf, D. G. F., Grothe, M. J., Fischer, F. U., Heinsen, H., Kilimann, I., Teipel, S. J., & Fellgiebel, A. (2013) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2013.11.002 · Cited by 53
Bridges, T. M., Kennedy, J. P., Noetzel, M. J., Breininger, M. L., Gentry, P. R., Conn, P. J., & Lindsley, C. W. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.109 · Cited by 54
Aging and Synaptic Plasticity: A Review
Bergado, J. A., & Almaguer, W. (2002) · Neural Plasticity · doi:10.1155/np.2002.217 · Cited by 55
Winters, B. D., Bartko, S. J., Saksida, L. M., & Bussey, T. J. (2007) · Learning & Memory · doi:10.1101/lm.634607 · Cited by 54
Counts, S., He, B., Che, S., Ginsberg, S. D., & Mufson, E. J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1196 · Cited by 54
Zarazúa, S., Bürger, S., Delgado, J. M., Jiménez-Capdeville, M. E., & Schliebs, R. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.03.004 · Cited by 52
Neuroprotective Role for Galanin in Alzheimer’s Disease
Counts, S., Perez, S. E., Ginsberg, S. D., & Mufson, E. J. (2010) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0346-0228-0_11 · Cited by 50
Chopin, P., Colpaert, F. C., & Marien, M. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.187 · Cited by 52
Pesavento, E., Capsoni, S., Domenici, L., & Cattaneo, A. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01937.x · Cited by 52
da Costa, J. S., Lopes, J. P. B., Russowsky, D., Petzhold, C. L., Borges, A. C. D. A., Ceschi, M. A., Konrath, E. L., Batassini, C., Lunardi, P. S., & Gonçalves, C. A. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.029 · Cited by 51
Cholinergic dysfunction in vascular dementia
Román, G. C. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0019-2 · Cited by 51
Ratia, M., Giménez‐Llort, L., Camps, P., Muñoz‐Torrero, D., Pérez, B., Clos, M. V., & Badı́a, A. (2012) · Neurodegenerative Diseases · doi:10.1159/000336427 · Cited by 50
Alrefaie, Z. A., & Alhayani, A. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.050 · Cited by 50
Lee, M.-R., Yun, B.-S., In, O.-H., & Sung, C. K. (2011) · Journal of Ginseng Research · doi:10.5142/jgr.2011.35.4.421 · Cited by 50
The length of hippocampal cholinergic fibers is reduced in the aging brain
Ypsilanti, A. R., da Cruz, M. T. G., Burgess, A., & Aubert, I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.001 · Cited by 54
Therapeutic Potential of Multifunctional Tacrine Analogues
Przybyłowska, M., Kowalski, S., Dzierzbicka, K., & Inkielewicz‐Stępniak, I. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180412091908 · Cited by 51
Kim, D. K. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976997 · Cited by 50
Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice
Machová, E., Jakubík, J., Michal, P., Oksman, M., Iivonen, H., Tanila, H., & Doležal, V. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.029 · Cited by 50
Stem cell transplantation for neurometabolic and neurodegenerative diseases
Shihabuddin, L. S., & Aubert, I. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.015 · Cited by 49
Evaluation of the cholinergic hypothesis in Alzheimer’s disease with neuropsychological methods
Fotiou, D. F., Καλτσάτου, Α., Tsiptsios, D., & Νάκου, Μ. (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0321-8 · Cited by 49
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model
Chen, Y., Dyakin, V. V., Branch, C. A., Ardekani, B. A., Yang, D., Guilfoyle, D. N., Peterson, J. N., Peterhoff, C. M., Ginsberg, S. D., Cataldo, A. M., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.026 · Cited by 50
Beneficial Effects of Citrus-Derived Polymethoxylated Flavones for Central Nervous System Disorders
Matsuzaki, K., & Ohizumi, Y. (2021) · Nutrients · doi:10.3390/nu13010145 · Cited by 53
Gu, G., Zhang, W., Li, M., Ni, J., & Wang, P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.073 · Cited by 48
Qin, J., Lan, W., Liu, Z., HUANG, J. C., Tang, H., & Wang, H. (2013) · Chemistry Central Journal · doi:10.1186/1752-153x-7-78 · Cited by 48
Real‐time activation of central cholinergic circuits during recognition memory
Bonnı̀, S., Ponzo, V., Lorenzo, F. D., Caltagirone, C., & Koch, G. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13588 · Cited by 48
Gibbs, R. B., Mauk, R., Nelson, D. A., & Johnson, D. A. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.03.003 · Cited by 48
Counts, S., Chen, E., Che, S., Ikonomović, M. D., Wuu, J., Ginsberg, S. D., DeKosky, S. T., & Mufson, E. J. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000090906 · Cited by 48
Kim, H.-J., Moon, W., & Han, S. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122320 · Cited by 47
van der Staay, F. J., & Bouger, P. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.05.010 · Cited by 47
Spatial and emotional memory in aged rats: a behavioral-statistical analysis
Bergado, J. A., Almaguer, W., Rojas, Y., Capdevila, V., & Frey, J. U. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.064 · Cited by 47
Kim, D. K., & Lee, K. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02976684 · Cited by 47
Smith, S. L., Dringenberg, H. C., Bennett, B. M., Thatcher, G. R. J., & Reynolds, J. N. (2000) · Neuroreport · doi:10.1097/00001756-200011270-00055 · Cited by 47
Chen, G., Chen, K. S., Kobayashi, D. T., Barbour, R., Motter, R. N., Games, D., Martin, S. J., & Morris, R. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3710-06.2007 · Cited by 47
Modeling cholinergic aspects of schizophrenia: Focus on the antimuscarinic syndrome
Barak, S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.006 · Cited by 50
Galanin – 25 years with a multitalented neuropeptide
Counts, S., Perez, S. E., & Mufson, E. J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8159-2 · Cited by 46
Comparison of the effects of antipsychotics on a delayed radial maze task in the rat
Wolff, M. C., & Leander, J. D. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1449-3 · Cited by 46
Motor cortex cholinergic dysfunction in CADASIL: A transcranial magnetic demonstration
Manganelli, F., Ragno, M., Cacchiò, G., Iodice, V., Trojano, L., Silvaggio, F., Scarcella, M., Grazioli, M., Santoro, L., & Perretti, A. (2007) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.10.011 · Cited by 45
Regulation of Cognitive Processing by Hippocampal Cholinergic Tone
Al‐Onaizi, M., Parfitt, G. M., Kolisnyk, B., Law, C. S. H., Guzmán, M. S., Barros, D. M., Leung, L.-W. S., Prado, M. A. M., & Prado, V. F. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhv349 · Cited by 46
Freo, U., Ricciardi, E., Pietrini, P., Schapiro, M. B., Rapoport, S. I., & Furey, M. L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2061 · Cited by 45
Dam, D. V., Coen, K., & Deyn, P. P. D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1010-x · Cited by 44
Jackisch, R., Förster, S., Kammerer, M. M., Rothmaier, A. K., Ehret, A., Zentner, J., & Feuerstein, T. J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1008 · Cited by 44
Srivastava, N., Seth, K., Khanna, V. K., Ansari, R. W., & Agrawal, A. K. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.08.002 · Cited by 44
Gearhart, D. A., Middlemore, M.-L., & Terry, A. V. (2005) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2005.06.009 · Cited by 44
Pang, K. C. H., Yoder, R. M., & Olton, D. S. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00018-5 · Cited by 44
Young-Bernier, M., Kamil, Y., Tremblay, F., & Davidson, P. S. R. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-17 · Cited by 47
Woodruff‐Pak, D. S. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00039-1 · Cited by 45
Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque
Holland, J. P., Liang, S. H., Rotstein, B. H., Collier, T. L., Stephenson, N. A., Greguric, I. D., & Vasdev, N. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3158 · Cited by 43
Harati, H., Barbelivien, A., Cosquer, B., Majchrzak, M. J., & Cassel, J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.031 · Cited by 43
Tota, S., Goel, R., Pachauri, S. D., Rajasekar, N., Najmi, A. K., Hanif, K., & Nath, C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2913-8 · Cited by 43
Kurinami, H., Sato, N., Shinohara, M., Takeuchi, D., Takeda, S., Shimamura, M., Ogihara, T., & Morishita, R. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.5.531 · Cited by 45
Cadete-Leite, A., Pereira, P. A., Madeira, M. D., & Paula-Barbosa, M. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00205-7 · Cited by 43
Almaguer‐Melian, W., Rojas-Reyes, Y., Alvare, A., Rosillo, J. C., Frey, J. U., & Bergado, J. A. (2004) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2004.08.002 · Cited by 42
Machová, E., Rudajev, V., Smyčková, H., Koivisto, H., Tanila, H., & Doležal, V. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.023 · Cited by 42
Hermanstyne, T. O., Kihira, Y., Misonou, H., Deitchler, A., Yanagawa, Y., & Misonou, H. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22457 · Cited by 39
Bartus, R. T., & Dean, R. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1365-7 · Cited by 40
Self-citationCentral Executive Dysfunction and Deferred Prefrontal Processing in Veterans With Gulf War Illness
Hubbard, N. A., Hutchison, J. L., Motes, M. A., Kojori, E. S., Bennett, I. J., Brigante, R. M., Haley, R. W., & Bart Rypma, A. (2013) · Clinical Psychological Science · doi:10.1177/2167702613506580 · Cited by 41
NeuroHIV and Use of Addictive Substances
Chang, S. L., Connaghan, K. P., Wei, Y., & Li, M. D. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00013-0 · Cited by 42
Kim, C. R., Kim, H. S., Choi, S. J., Kim, J. K., Gim, M. C., Kim, Y., & Shin, D.-H. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.4117 · Cited by 42
Xie, K., Qin, Q., Long, Z., Yang, Y., Peng, C., Xi, C., Li, L., Wu, Z., Daria, V., Zhao, Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.602887 · Cited by 41
Effect of voluntary running on adult hippocampal neurogenesis in cholinergic lesioned mice
Ho, N. F., Han, S. P., & Dawe, G. S. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-57 · Cited by 43
Cholinergic Neurons and Networks Revisited
Butcher, L. L., & Woolf, N. J. (2004) · Elsevier eBooks · doi:10.1016/b978-012547638-6/50036-5 · Cited by 41
Selective immunolesions of CH4 cholinergic neurons do not disrupt spatial memory in rats
Galani, R., Lehmann, O., Bolmont, T., Aloy, E. M., Bertrand, F., Lazarus, C., Jeltsch‐David, H., & Cassel, J. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00674-1 · Cited by 41
Steinlein, O. K., Hoda, J., Bertrand, S., & Bertrand, D. (2011) · Seizure · doi:10.1016/j.seizure.2011.10.003 · Cited by 40
Denya, I., Malan, S. F., Enogieru, A. B., Omoruyi, S. I., Ekpo, O. E., Kapp, E., Zindo, F. T., & Joubert, J. (2018) · MedChemComm · doi:10.1039/c7md00569e · Cited by 41
Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease
Mufson, E. J., Counts, S., Che, S., & Ginsberg, S. D. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)58010-0 · Cited by 40
Hou, Y., Wu, C. F., Yang, J., & Guo, T. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.001 · Cited by 40
Araujo, J. A., Studzinski, C. M., Head, E., Cotman, C. W., & Milgram, N. W. (2005) · AGE · doi:10.1007/s11357-005-4001-z · Cited by 40
Devan, B. D., Pistell, P. J., Daffin, L. W., Nelson, C. M., Duffy, K. B., Bowker, J. L., Bharati, I. S., Sierra‐Mercado, D., Spangler, E. L., & Ingram, D. K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.008 · Cited by 40
Nicotinic receptor modulation: Advantages for successful Alzheimer’s disease therapy
Geerts, H., Finkel, L., Carr, R. A., & Spiros, Ä. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_19 · Cited by 40
Extensive Lesions of Cholinergic Basal Forebrain Neurons Do Not Impair Spatial Working Memory
Vuckovich, J. A., Semel, M. E., & Baxter, M. G. (2004) · Learning & Memory · doi:10.1101/lm.63504 · Cited by 39
Rizzo, S., Bisi, A., Bartolini, M., Mancini, F., Belluti, F., Gobbi, S., Andrisano, V., & Rampa, A. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.004 · Cited by 39
Probabilistic Computational Neurogenetic Modeling: From Cognitive Systems to Alzheimer's Disease
Kasabov, N. K., Schliebs, R., & Kojima, H. (2011) · IEEE Transactions on Autonomous Mental Development · doi:10.1109/tamd.2011.2159839 · Cited by 40
Metadata
- Authors
- Bartus, R. T.
- Affiliations
- Alkermes (United States) (US)
- Corresponding author
- Bartus, Raymond T.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 163
- Issue
- 2
- Pages
- 495-529
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2026745182
- Cited by
- 829
- References
- 231
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 19 · 2023: 21 · 2022: 42 · 2021: 34 · 2020: 26 · 2019: 22 · 2018: 32 · 2017: 38 · 2016: 34 · 2015: 24 · 2014: 30 · 2013: 40 · 2012: 38
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- cholinergic hypothesis, Alzheimer's disease, neurodegenerative diseases, animal models of disease, Alzheimer's disease treatment, palliative care, cholinesterase inhibitors
- MeSH terms
- Age Factors, Alzheimer Disease, Animals, Cognition, Disease Models, Animal, Forecasting, Humans, Memory Disorders, Cholinergic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review